IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MAGRINI, STEFANO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.645
AS - Asia 10.055
EU - Europa 8.349
SA - Sud America 2.433
AF - Africa 199
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 18
Totale 38.724
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.377
CN - Cina 3.430
SG - Singapore 3.330
UA - Ucraina 2.336
BR - Brasile 2.084
HK - Hong Kong 1.536
DE - Germania 1.367
IT - Italia 1.099
FI - Finlandia 627
VN - Vietnam 575
IE - Irlanda 545
PL - Polonia 541
RU - Federazione Russa 464
GB - Regno Unito 431
TR - Turchia 430
FR - Francia 418
IN - India 198
AR - Argentina 136
CA - Canada 135
SE - Svezia 122
BD - Bangladesh 114
NL - Olanda 81
MX - Messico 75
EC - Ecuador 74
ID - Indonesia 74
IQ - Iraq 73
ZA - Sudafrica 71
EE - Estonia 65
CZ - Repubblica Ceca 53
JP - Giappone 49
UZ - Uzbekistan 37
CO - Colombia 34
ES - Italia 32
MA - Marocco 32
BE - Belgio 31
VE - Venezuela 31
AT - Austria 30
PK - Pakistan 30
PY - Paraguay 29
SA - Arabia Saudita 24
EU - Europa 23
KE - Kenya 22
GR - Grecia 19
JO - Giordania 17
IL - Israele 16
AU - Australia 15
CL - Cile 15
EG - Egitto 15
LT - Lituania 15
TN - Tunisia 15
AZ - Azerbaigian 14
PE - Perù 14
NP - Nepal 13
AE - Emirati Arabi Uniti 12
DO - Repubblica Dominicana 11
MY - Malesia 10
JM - Giamaica 9
KG - Kirghizistan 9
KZ - Kazakistan 9
BG - Bulgaria 8
BY - Bielorussia 8
CH - Svizzera 8
DZ - Algeria 8
IR - Iran 8
OM - Oman 8
PA - Panama 8
UY - Uruguay 8
BO - Bolivia 7
LA - Repubblica Popolare Democratica del Laos 7
TT - Trinidad e Tobago 7
AL - Albania 6
DK - Danimarca 6
HN - Honduras 6
KW - Kuwait 6
MU - Mauritius 6
PT - Portogallo 6
SN - Senegal 6
BB - Barbados 5
CR - Costa Rica 5
HU - Ungheria 5
LV - Lettonia 5
ET - Etiopia 4
KR - Corea 4
LB - Libano 4
MK - Macedonia 4
NG - Nigeria 4
SK - Slovacchia (Repubblica Slovacca) 4
UG - Uganda 4
AO - Angola 3
CI - Costa d'Avorio 3
KH - Cambogia 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
RO - Romania 3
SV - El Salvador 3
AM - Armenia 2
BW - Botswana 2
GE - Georgia 2
GT - Guatemala 2
IS - Islanda 2
Totale 38.699
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.781
Fairfield 1.744
Woodbridge 1.608
Singapore 1.561
Hong Kong 1.531
Ashburn 1.430
Houston 1.158
Ann Arbor 899
Princeton 806
Chandler 803
Cambridge 775
Beijing 713
Wilmington 702
Seattle 692
Nanjing 579
Dublin 541
Warsaw 534
New York 411
Los Angeles 363
Istanbul 361
Dearborn 268
Helsinki 259
Nanchang 219
Buffalo 205
Des Moines 201
Dallas 200
Moscow 197
Ho Chi Minh City 193
The Dalles 191
São Paulo 185
Munich 171
Changsha 150
Milan 147
Brescia 144
Shenyang 139
Hebei 125
San Diego 121
Tianjin 120
Jinan 117
Shanghai 117
Hanoi 102
San Francisco 95
Jiaxing 89
Redondo Beach 76
Rio de Janeiro 72
Kunming 65
Tallinn 65
Chicago 63
Verona 62
London 60
Hangzhou 58
Dong Ket 56
Boardman 50
Rome 48
Turku 48
Washington 47
Santa Clara 46
Brasília 45
Tokyo 45
Zhengzhou 45
Belo Horizonte 44
Montreal 42
Guangzhou 41
Brooklyn 40
Lancaster 39
Nuremberg 38
Brno 37
Toronto 37
Denver 36
Jakarta 34
Johannesburg 34
Ningbo 34
Quito 34
Tashkent 34
Lanzhou 32
Taizhou 31
Augusta 30
Brussels 30
Phoenix 30
Curitiba 29
Dhaka 29
Norwalk 29
Atlanta 27
Haiphong 27
Poplar 26
Pune 26
Salvador 26
Boston 25
Changchun 25
Porto Alegre 25
Haikou 24
Kocaeli 24
Frankfurt am Main 23
Guarulhos 23
Stockholm 23
Chennai 22
Guayaquil 22
Nairobi 22
Orange 22
Da Nang 21
Totale 24.895
Salva come PNG Salva come JPEG
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 395
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 254
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 238
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 230
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 220
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 206
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 206
Pros-IT CNR: an Italian prostate cancer monitoring project 205
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 197
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 195
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 191
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 190
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 187
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 184
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 177
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 176
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 176
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 171
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 168
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 167
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 165
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 165
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 165
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 164
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: evolving technical choices and survival 162
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 160
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 160
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 159
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 158
Role of external beam radiotherapy in the treatment of relapsing meningioma 157
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 156
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 156
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 156
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 154
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 152
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society 152
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 149
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 149
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 149
Carboplatin (JM8), etoposide (VP16) and thoracic Irradiation for small cell lung cancer (S.C.L.C.): An evaluation of lung toxicity 148
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns 147
Could Concomitant Radio-Chemotherapy Improve the Outcomes of Early-Stage Node Negative Anal Canal Cancer Patients? A Retrospective Analysis of 122 Patients 147
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 146
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 145
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 144
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 italian radiation oncology centers 143
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 143
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 143
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 142
From Molecular to Clinical Radiation Biology of Glioblastoma 142
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 142
Non-palliative radiotherapy in ab initio oligometastatic prostate cancer: an Italian national survey 141
Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial. 140
"Radiotherapy versus combined modality in early stages", 140
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 140
Open-source, low cost, high-reliability solutions for digital imaging systrems: example of a dicom router/Soluzioni Open Source per sistemi Low Cost e High Reliability per l'imaging digitale: l'esempio di un dicom router. 138
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 137
Extreme hypofractionation for early prostate cancer: Biology meets technology 137
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 137
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study 136
Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series 133
Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma 133
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 133
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 133
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 132
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 132
Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients 131
GUROPA survey: genito-urinary radiation oncology prescription attitudes 131
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 130
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 130
Information Retrieval in Medicine: an Extensive Experimental Study 129
Postoperative radiotherapy after radical prostatectomy for prostate carcinoma: the experience of the Brescia Radium Institute. 126
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 126
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 126
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 126
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 126
Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study. 125
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 125
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma 125
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 124
Which role for radiation therapy in ethmoid cancer? A retrospective analysis of 84 cases from a single Institution 124
A reappraisal of the role of PET and CT/PET in early stage Hodgkin's Disease (HD) in the experience of the florence and Brescia Universities. 124
Duration of androgen suppression in the treatment of prostate cancer 124
Cetuximab and Radiation Therapy in Head and Neck Cancer 123
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 123
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair 123
"CHEMOTHERAPY VERSUS RADIOTHERAPY IN EARLY-STAGE HODGKIN'S DISEASE: EVIDENCE OF A MORE DIFFICULT RESCUE FOR PATIENTS RELAPSED AFTER CHEMOTHERAPY" 122
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 122
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 120
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 119
Radiotherapy in Small Cell Lung Cancer 118
Association between testicular cancer and spina bifida occulta 118
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 118
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 118
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 118
Radioterapia ("extended field") versus chemioterapia (MOPP) nel trattamento del m.di Hodgkin (stadio patologico I-IIA): risultati a 10 anni di uno studio prospettico randomizzato italiano 117
Second malignancies in Hodgkin's disease 117
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 117
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 117
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. 116
Totale 15.073
Salva come PNG Salva come JPEG
Categoria #
all - tutte 202.085
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 202.085
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.323 0 0 0 0 0 635 130 584 781 470 523 200
2021/20222.644 143 488 47 104 44 137 113 211 155 305 229 668
2022/20232.483 449 133 72 160 173 638 8 236 305 143 83 83
2023/20242.909 131 48 253 129 119 529 91 116 826 67 81 519
2024/20256.457 44 80 35 801 819 557 714 184 557 511 1.296 859
2025/20267.616 1.172 1.913 1.118 2.165 1.102 146 0 0 0 0 0 0
Totale 39.234